Impax announces the launch of an authorized generic version of Solodyn® (minocycline HCl)
Impax Laboratories announced it has launched an authorized generic version of Solodyn® (minocycline HCl) extended-release tablets, 65 mg and 115 mg. Minocycline HCl ER tablets, 65 mg and 115 mg, had annual U.S. sales of $148 million according to IQVIA® for the 12 months ending Dec. 2017. February 20, 2018